Symptom burdens related to chemotherapy-induced anemia in stage IV cancerDecember 5, 2018Patient & Survivor CareBreast CancerLung CancerLymphoma & Plasma Cell Disorders
ASCO 2018: Less is more as ‘tailoring’ takes on new meaningJune 21, 2018Breast CancerLung CancerGenitourinary Cancer
Qualitative assessment of organizational barriers to optimal lung cancer care in a community hospital setting in the United StatesApril 29, 2018Lung CancerPatient & Survivor Care
Bevacizumab-awwb becomes first biosimilar approved for cancer treatmentApril 29, 2018Gynecologic CancerGastroenterologyLung Cancer
Analgesic management in radiation oncology for painful bone metastasesApril 8, 2018Patient & Survivor CareBreast CancerGenitourinary CancerLung Cancer
Hospitalizations for fracture in patients with metastatic disease: primary source lesions in the United StatesFebruary 19, 2018Patient & Survivor CareLung Cancer
Clinical presentation, diagnosis, and management of typical and atypical bronchopulmonary carcinoidJanuary 10, 2018Lung Cancer
Expanding treatment options for diverse neuroendocrine tumorsDecember 15, 2017GastroenterologyLung Cancer
Brigatinib approval yields additional treatment options for crizotinib-resistant, ALK-positive NSCLC patientsDecember 15, 2017Lung Cancer
PD-L1-targeting drug atezolizumab nabs approval for non-small cell lung cancerDecember 1, 2017Lung Cancer
